Geneva Advisors’s Intuitive Surgical ISRG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
$54.6M Buy
525,834
+17,757
+3% +$1.71M 0.94% 35
2017
Q1
$43.3M Sell
508,077
-31,707
-6% -$2.5M 0.77% 42
2016
Q4
$38M Sell
539,784
-54,882
-9% -$4.04M 0.74% 46
2016
Q3
$47.9M Buy
594,666
+149,778
+34% +$11.5M 0.9% 39
2016
Q2
$32.7M Buy
444,888
+436,311
+5,087% +$30.7M 0.65% 56
2016
Q1
$573K Buy
8,577
+90
+1% +$5.58K 0.01% 404
2015
Q4
$515K Hold
8,487
0.01% 412
2015
Q3
$433K Sell
8,487
-1,080
-11% -$61.2K 0.01% 416
2015
Q2
$515K Sell
9,567
-855
-8% -$47.8K 0.01% 422
2015
Q1
$585K Sell
10,422
-22,275
-68% -$1.26M 0.01% 385
2014
Q4
$1.92M Buy
32,697
+21,861
+202% +$1.22M 0.04% 205
2014
Q3
$556K Sell
10,836
-1,152
-10% -$57.2K 0.01% 401
2014
Q2
$549K Buy
11,988
+270
+2% +$11.9K 0.01% 419
2014
Q1
$570K Sell
11,718
-1,125
-9% -$53K 0.01% 363
2013
Q4
$548K Sell
12,843
-1,341
-9% -$56.4K 0.01% 320
2013
Q3
$593K Sell
14,184
-883,278
-98% -$39M 0.01% 313
2013
Q2
$50.5M Buy
+897,462
New +$49.4M 1.17% 33

Other funds holding ISRG

Geneva Advisors's ISRG Position: Q2 2017 in Review

Geneva Advisors increased its Intuitive Surgical (ISRG) stake by 3.5% in Q2 2017, buying an estimated $1.71M and bringing the position to 525,834 shares worth $54.6M. The position accounts for 0.94% of the portfolio, ranked #35.

Geneva Advisors first reported a position in ISRG in Q2 2013 and has held it in 17 quarters since. 635 funds tracked by Wall St. Rank hold ISRG as of Q2 2017.

  • Geneva Advisors held 525,834 shares of Intuitive Surgical worth $54.6M as of Q2 2017.
  • Geneva Advisors bought 17,757 Intuitive Surgical shares in Q2 2017, an estimated $1.71M.
  • Intuitive Surgical made up 0.94% of Geneva Advisors's portfolio in Q2 2017, its #35 holding.
  • Geneva Advisors first reported a position in Intuitive Surgical in Q2 2013 and has held it in 17 quarters since.
  • 635 funds tracked by Wall St. Rank held Intuitive Surgical as of Q2 2017.

Based on Geneva Advisors's 13F filing for Q2 2017, filed 7 Aug 2017.